QULIPTA 10 MG TABLET

Atogepant
$38.3668per EA

Strength

10 mg/1

Manufacturer

AbbVie Inc.

NDC

00074709530

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/2/2026

Active Ingredients

ATOGEPANT

Approval Type

New Drug (NDA)

FDA Application

NDA215206

On Market Since

9/30/2021

Pharmacological Classes

Calcitonin Gene-related Peptide Receptor Antagonist
Calcitonin Gene-related Peptide Receptor Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.0%

1Y

+4.7%

3Y

+14.8%

5Y

N/A

All

+20.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.